Glyceraldehyde 3-phosphate dehydrogenase

For other uses, see Glyceraldehyde-3-phosphate dehydrogenase (disambiguation).

GAPDH
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 1U8F, 1ZNQ, 3GPD, 4WNC, 4WNI
Identifiers
Aliases	GAPDH , GAPD, G3PD, HEL-S-162eP, glyceraldehyde-3-phosphate dehydrogenase
External IDs	OMIM: 138400; MGI: 5434255; HomoloGene: 107053; GeneCards: GAPDH; OMA:GAPDH - orthologs
Gene location (Human) Chr. Chromosome 12 (human) [1] Band 12p13.31 Start 6,534,512 bp [1] End 6,538,374 bp [1]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in frontal pole pons paraflocculus of cerebellum Brodmann area 10 triceps brachii muscle deltoid muscle Skeletal muscle tissue of biceps brachii Brodmann area 46 lateral nuclear group of thalamus body of tongue n/a More reference expression data BioGPS n/a
Gene ontology Molecular function transferase activity microtubule binding NAD binding oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor protein binding peptidyl-cysteine S-nitrosylase activity NADP binding identical protein binding oxidoreductase activity glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity aspartic-type endopeptidase inhibitor activity disordered domain specific binding Cellular component vesicle nuclear membrane membrane intracellular membrane-bounded organelle microtubule cytoskeleton lipid droplet plasma membrane perinuclear region of cytoplasm GAIT complex cytoskeleton extracellular exosome cytosol nucleus extracellular matrix cytoplasm ribonucleoprotein complex Biological process peptidyl-cysteine S-trans-nitrosylation neuron apoptotic process gluconeogenesis negative regulation of translation glycolytic process canonical glycolysis protein stabilization cellular response to interferon-gamma regulation of translation microtubule cytoskeleton organization regulation of macroautophagy apoptotic process glucose metabolic process negative regulation of endopeptidase activity antimicrobial humoral immune response mediated by antimicrobial peptide Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 2597 100042025 Ensembl ENSG00000111640 n/a UniProt P04406 P16858 RefSeq (mRNA) NM_002046 NM_001256799 NM_001289745 NM_001289746 NM_001357938 NM_001357943 NM_001357944 XM_001476707 RefSeq (protein) NP_001243728 NP_001276674 NP_001276675 NP_002037 NP_001344872 NP_001276655 NP_032110 Location (UCSC) Chr 12: 6.53 – 6.54 Mb n/a PubMed search [2] [3]
Wikidata
View/Edit Human View/Edit Mouse

Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain
determinants of enzyme thermostability observed in the molecular structure of thermus aquaticus d-glyceraldehyde-3-phosphate dehydrogenase at 2.5 angstroms resolution
Identifiers
Symbol	Gp_dh_N
Pfam	PF00044
Pfam clan	CL0063
InterPro	IPR020828
PROSITE	PDOC00069
SCOP2	1gd1 / SCOPe / SUPFAM
Available protein structures: Pfam   structures / ECOD   PDB RCSB PDB; PDBe; PDBj PDBsum structure summary

Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain
crystal structure of glyceraldehyde-3-phosphate dehydrogenase from pyrococcus horikoshii ot3
Identifiers
Symbol	Gp_dh_C
Pfam	PF02800
Pfam clan	CL0139
InterPro	IPR020829
PROSITE	PDOC00069
SCOP2	1gd1 / SCOPe / SUPFAM
Available protein structures: Pfam   structures / ECOD   PDB RCSB PDB; PDBe; PDBj PDBsum structure summary

Glyceraldehyde 3-phosphate dehydrogenase (abbreviated GAPDH) (EC 1.2.1.12) is an enzyme of about 37kDa that catalyzes the sixth step of glycolysis and thus serves to break down glucose for energy and carbon molecules. In addition to this long established metabolic function, GAPDH has recently been implicated in several non-metabolic processes, including transcription activation, initiation of apoptosis, ^[4] ER-to-Golgi vesicle shuttling, and fast axonal, or axoplasmic transport. ^[5] In sperm, a testis-specific isoenzyme GAPDHS is expressed.

Structure

Under normal cellular conditions, cytoplasmic GAPDH exists primarily as a tetramer. This form is composed of four identical 37-kDa subunits containing a single catalytic thiol group each and critical to the enzyme's catalytic function. ^{[6] [7]} Nuclear GAPDH has increased isoelectric point (pI) of pH 8.3–8.7. ^[7] Of note, the cysteine residue C152 in the enzyme's active site is required for the induction of apoptosis by oxidative stress. ^[7] Notably, post-translational modifications of cytoplasmic GAPDH contribute to its functions outside of glycolysis. ^[6]

GAPDH is encoded by a single gene that produces a single mRNA transcript with 8 splice variants, though an isoform does exist as a separate gene that is expressed only in spermatozoa. ^[7]

Reaction

glyceraldehyde 3-phosphate	glyceraldehyde phosphate dehydrogenase		D-glycerate 1,3-bisphosphate
	NAD+ +Pi	NADH + H+
	NAD+ +Pi	NADH + H+

Compound C00118 at KEGG Pathway Database.Enzyme 1.2.1.12 at KEGG Pathway Database.Reaction R01063 at KEGG Pathway Database.Compound C00236 at KEGG Pathway Database.

Two-step conversion of G3P

The first reaction is the oxidation of glyceraldehyde 3-phosphate (G3P) at the position-1 (in the diagram it is shown as the 4th carbon from glycolysis), in which an aldehyde is converted into a carboxylic acid (ΔG°'=-50 kJ/mol (−12kcal/mol)) and NAD+ is simultaneously reduced endergonically to NADH.

The energy released by this highly exergonic oxidation reaction drives the endergonic second reaction (ΔG°'=+50 kJ/mol (+12kcal/mol)), in which a molecule of inorganic phosphate is transferred to the GAP intermediate to form a product with high phosphoryl-transfer potential: 1,3-bisphosphoglycerate (1,3-BPG).

This is an example of phosphorylation coupled to oxidation, and the overall reaction is somewhat endergonic (ΔG°'=+6.3 kJ/mol (+1.5)). Energy coupling here is made possible by GAPDH.

Mechanism

GAPDH uses covalent catalysis and general base catalysis to decrease the very large activation energy of the second step (phosphorylation) of this reaction.

1: Oxidation

First, a cysteine residue in the active site of GAPDH attacks the carbonyl group of G3P, creating a hemithioacetal intermediate (covalent catalysis).

The hemithioacetal is deprotonated by a histidine residue in the enzyme's active site (general base catalysis). Deprotonation encourages the reformation of the carbonyl group in the subsequent thioester intermediate and ejection of a hydride ion.

Next, an adjacent, tightly bound molecule of NAD⁺ accepts the hydride ion, forming NADH while the hemithioacetal is oxidized to a thioester.

This thioester species is much higher in energy (less stable) than the carboxylic acid species that would result if G3P were oxidized in the absence of GAPDH (the carboxylic acid species is so low in energy that the energy barrier for the second step of the reaction (phosphorylation) would be too high, and the reaction, therefore, too slow and unfavorable for a living organism).

2: Phosphorylation

NADH leaves the active site and is replaced by another molecule of NAD⁺, the positive charge of which stabilizes the negatively charged carbonyl oxygen in the transition state of the next and ultimate step. Finally, a molecule of inorganic phosphate attacks the thioester and forms a tetrahedral intermediate, which then collapses to release 1,3-bisphosphoglycerate, and the thiol group of the enzyme's cysteine residue.

Regulation

This protein may use the morpheein model of allosteric regulation. ^[8]

Function

Metabolic

As its name indicates, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) catalyses the conversion of glyceraldehyde 3-phosphate to D-glycerate 1,3-bisphosphate. This is the 6th step in the glycolytic breakdown of glucose, an important pathway of energy and carbon molecule supply which takes place in the cytosol of eukaryotic cells. The conversion occurs in two coupled steps. The first is favourable and allows the second unfavourable step to occur.

Adhesion

One of the GAPDH moonlighting functions is its role in adhesion and binding to other partners. Bacterial GAPDH from Mycoplasma and Streptococcus and fungal GAPDH from Paracoccidioides brasiliensis are known to bind with the human extracellular matrix component and act in adhesion. ^{[9] [10] [11]} GAPDH is found to be surface bound contributing in adhesion and also in competitive exclusion of harmful pathogens. ^[12] GAPDH from Candida albicans is found to cell-wall associated and binds to Fibronectin and Laminin. ^[13] GAPDH from probiotics species are known to bind human colonic mucin and ECM, resulting in enhanced colonization of probiotics in the human gut. ^{[14] [15] [16]} Patel D. et al., showed that Lactobacillus acidophilus GAPDH binds with mucin, acting in adhesion. ^[17]

Transcription and apoptosis

GAPDH can itself activate transcription. The OCA-S transcriptional coactivator complex contains GAPDH and lactate dehydrogenase, two proteins previously only thought to be involved in metabolism. GAPDH moves between the cytosol and the nucleus and may thus link the metabolic state to gene transcription. ^[18]

In 2005, Hara et al. showed that GAPDH initiates apoptosis. This is not a third function, but can be seen as an activity mediated by GAPDH binding to DNA like in transcription activation, discussed above. The study demonstrated that GAPDH is S-nitrosylated by NO in response to cell stress, which causes it to bind to the protein SIAH1, a ubiquitin ligase. The complex moves into the nucleus where Siah1 targets nuclear proteins for degradation, thus initiating controlled cell shutdown. ^[19] In subsequent study the group demonstrated that deprenyl, which has been used clinically to treat Parkinson's disease, strongly reduces the apoptotic action of GAPDH by preventing its S-nitrosylation and might thus be used as a drug. ^[20]

Metabolic switch

GAPDH acts as a reversible metabolic switch under oxidative stress. ^[21] When cells are exposed to oxidants, they need excessive amounts of the antioxidant cofactor NADPH. In the cytosol, NADPH is reduced from NADP+ by several enzymes, three of them catalyze the first steps of the pentose phosphate pathway. Oxidant-treatments cause an inactivation of GAPDH. This inactivation re-routes temporally the metabolic flux from glycolysis to the pentose phosphate pathway, allowing the cell to generate more NADPH. ^[22] Under stress conditions, NADPH is needed by some antioxidant-systems including glutaredoxin and thioredoxin as well as being essential for the recycling of gluthathione.

ER-to-Golgi transport

GAPDH also appears to be involved in the vesicle transport from the endoplasmic reticulum (ER) to the Golgi apparatus which is part of shipping route for secreted proteins. It was found that GAPDH is recruited by rab2 to the vesicular-tubular clusters of the ER where it helps to form COP 1 vesicles. GAPDH is activated via tyrosine phosphorylation by Src. ^[23]

Additional functions

GAPDH, like many other enzymes, has multiple functions. In addition to catalysing the 6th step of glycolysis, recent evidence implicates GAPDH in other cellular processes. GAPDH has been described to exhibit higher order multifunctionality in the context of maintaining cellular iron homeostasis, ^[24] specifically as a chaperone protein for labile heme within cells. ^[25] This came as a surprise to researchers but it makes evolutionary sense to re-use and adapt existing proteins instead of evolving a novel protein from scratch.

Use as loading control

Because the GAPDH gene is often stably and constitutively expressed at high levels in most tissues and cells, it is considered a housekeeping gene. For this reason, GAPDH is commonly used by biological researchers as a loading control for western blot and as a control for qPCR. However, researchers have reported different regulation of GAPDH under specific conditions. ^[26] For example, the transcription factor MZF-1 has been shown to regulate the GAPDH gene. ^[27] Hypoxia also strongly upregulates GAPDH. ^[28] Therefore, the use of GAPDH as loading control has to be considered carefully.

Cellular distribution

All steps of glycolysis take place in the cytosol and so does the reaction catalysed by GAPDH. In red blood cells, GAPDH and several other glycolytic enzymes assemble in complexes on the inside of the cell membrane. The process appears to be regulated by phosphorylation and oxygenation. ^[29] Bringing several glycolytic enzymes close to each other is expected to greatly increase the overall speed of glucose breakdown. Recent studies have also revealed that GAPDH is expressed in an iron dependent fashion on the exterior of the cell membrane a where it plays a role in maintenance of cellular iron homeostasis. ^{[30] [31]}

Clinical significance

Cancer

GAPDH is overexpressed in multiple human cancers, such as cutaneous melanoma, and its expression is positively correlated with tumor progression. ^{[32] [33]} Its glycolytic and antiapoptotic functions contribute to proliferation and protection of tumor cells, promoting tumorigenesis. Notably, GAPDH protects against telomere shortening induced by chemotherapeutic drugs that stimulate the sphingolipid ceramide. Meanwhile, conditions like oxidative stress impair GAPDH function, leading to cellular aging and death. ^[7] Moreover, depletion of GAPDH has managed to induce senescence in tumor cells, thus presenting a novel therapeutic strategy for controlling tumor growth. ^[34]

Neurodegeneration

GAPDH has been implicated in several neurodegenerative diseases and disorders, largely through interactions with other proteins specific to that disease or disorder. These interactions may affect not only energy metabolism but also other GAPDH functions. ^[6] For example, GAPDH interactions with beta-amyloid precursor protein (betaAPP) could interfere with its function regarding the cytoskeleton or membrane transport, while interactions with huntingtin could interfere with its function regarding apoptosis, nuclear tRNA transport, DNA replication, and DNA repair. In addition, nuclear translocation of GAPDH has been reported in Parkinson's disease (PD), and several anti-apoptotic PD drugs, such as rasagiline, function by preventing the nuclear translocation of GAPDH. It is proposed that hypometabolism may be one contributor to PD, but the exact mechanisms underlying GAPDH involvement in neurodegenerative disease remains to be clarified. ^[35] The SNP rs3741916 in the 5' UTR of the GAPDH gene may be associated with late onset Alzheimer's disease. ^[36]

Interactions

Protein binding partners

GAPDH participates in a number of biological functions through its protein–protein interactions with:

• tubulin to facilitate microtubule bundling; ^[6]
• actin to facilitate actin polymerization; ^[6]
• VDAC1 to induce mitochondrial membrane permeabilization (MMP) and apoptosis; ^[6]
• Inositol 1,4,5-trisphosphate receptor to regulate intracellular Ca2+ signaling; ^[6]
• Oct-1 to form the coactivator complex OCA-S, which is required for histone H2B synthesis during S phase of the cell cycle; ^[7]
• p22 to aid microtubule organization; ^[7]
• Rab2 to facilitate endoplasmic reticulum (ER)–golgi transport; ^[7]
• Transferrin on the surface of diverse cells and in extracellular fluid; ^{[7] [31] [37]}
• Lactate dehydrogenase; ^[7]
• Lactoferrin; ^[38]
• Apurinic/apyrimidinic endonuclease (APE1), thus converting oxidized APE1 to its reduced form, to restart its endonuclease activity; ^[7]
• Promyelocytic leukaemia protein (PML) in an RNA-dependent fashion; ^[7]
• Rheb to sequester the GTPase during low glucose conditions; ^[7]
• Siah1 to form a complex that translocates to the nucleus, where it ubiquitinates and degrades nuclear proteins during nitrosative stress conditions; ^[7]
• GAPDH's competitor of Siah protein enhances life (GOSPEL) to block GAPDH interaction with Siah1 and, thus, cell death in response to oxidative stress; ^[7]
• p300/CREB binding protein (CBP), which acetylates GAPDH and, in turn, enhances the acetylation of additional apoptotic targets; ^[7]
• skeletal muscle-specific Ca2+/calmodulin-dependent protein kinase; ^[7]
• Akt; ^[7]
• Beta-amyloid precursor protein (betaAPP); ^[35]
• Huntingtin. ^[35]
• GAPDH can self-associate into homotypic oligomers/aggregates

Nucleic acid binding partners

GAPDH binds to single-stranded RNA ^[39] and DNA and a number of nucleic acid binding partners have been identified: ^[7]

• tRNA,
• Hepatitis A viral RNA,
• Hepatitis B viral RNA,
• Hepatitis C viral RNA,
• HPIV3,
• lymphokine mRNA,
• IFN-γ mRNA,
• JEV mRNA, and
• telomeric DNA.

Inhibitors

• Desmethylselegiline ^[40]
• Koningic acid
• Rasagiline ^[40]
• Selegiline ^[40]

Interactive pathway map

Click on genes, proteins and metabolites below to link to respective articles. ^{[§ 1]}

[[File:

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

|alt=Glycolysis and Gluconeogenesis edit]]

Glycolysis and Gluconeogenesis edit

1. The interactive pathway map can be edited at WikiPathways: "GlycolysisGluconeogenesis_WP534".

References

1. GRCh38: Ensembl release 89: ENSG00000111640 – Ensembl, May 2017
2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
3. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C (April 2007). "GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization". Oncogene. 26 (18): 2606–2620. doi:10.1038/sj.onc.1210074. PMID   17072346. S2CID   20291542.
5. Zala D, Hinckelmann MV, Yu H, Lyra da Cunha MM, Liot G, Cordelières FP, Marco S, Saudou F (January 2013). "Vesicular glycolysis provides on-board energy for fast axonal transport". Cell. 152 (3): 479–491. doi: 10.1016/j.cell.2012.12.029 . PMID   23374344.
6. Tristan C, Shahani N, Sedlak TW, Sawa A (February 2011). "The diverse functions of GAPDH: views from different subcellular compartments". Cellular Signalling. 23 (2): 317–323. doi:10.1016/j.cellsig.2010.08.003. PMC   3084531 . PMID   20727968.
7. Nicholls C, Li H, Liu JP (August 2012). "GAPDH: a common enzyme with uncommon functions". Clinical and Experimental Pharmacology & Physiology. 39 (8): 674–679. doi:10.1111/j.1440-1681.2011.05599.x. PMID   21895736. S2CID   23499684.
8. Selwood T, Jaffe EK (March 2012). "Dynamic dissociating homo-oligomers and the control of protein function". Archives of Biochemistry and Biophysics. 519 (2): 131–143. doi:10.1016/j.abb.2011.11.020. PMC   3298769 . PMID   22182754.
9. Dumke R, Hausner M, Jacobs E (August 2011). "Role of Mycoplasma pneumoniae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mediating interactions with the human extracellular matrix". Microbiology. 157 (Pt 8): 2328–2338. doi: 10.1099/mic.0.048298-0 . PMID   21546586.
10. Brassard J, Gottschalk M, Quessy S (August 2004). "Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde-3-phosphate dehydrogenase and its involvement as an adhesin". Veterinary Microbiology. 102 (1–2): 87–94. doi:10.1016/j.vetmic.2004.05.008. PMID   15288930.
11. Barbosa MS, Báo SN, Andreotti PF, de Faria FP, Felipe MS, dos Santos Feitosa L, Mendes-Giannini MJ, Soares CM (January 2006). "Glyceraldehyde-3-phosphate dehydrogenase of Paracoccidioides brasiliensis is a cell surface protein involved in fungal adhesion to extracellular matrix proteins and interaction with cells". Infection and Immunity. 74 (1): 382–389. doi:10.1128/IAI.74.1.382-389.2006. PMC   1346668 . PMID   16368993.
12. Ramiah K, van Reenen CA, Dicks LM (1 July 2008). "Surface-bound proteins of Lactobacillus plantarum 423 that contribute to adhesion of Caco-2 cells and their role in competitive exclusion and displacement of Clostridium sporogenes and Enterococcus faecalis". Research in Microbiology. 159 (6): 470–475. doi: 10.1016/j.resmic.2008.06.002 . PMID   18619532.
13. Gozalbo D, Gil-Navarro I, Azorín I, Renau-Piqueras J, Martínez JP, Gil ML (May 1998). "The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein". Infection and Immunity. 66 (5): 2052–2059. doi:10.1128/IAI.66.5.2052-2059.1998. PMC   108162 . PMID   9573088.
14. Deng Z, Dai T, Zhang W, Zhu J, Luo XM, Fu D, Liu J, Wang H (December 2020). "Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion of Lactobacillus reuteri to Host Mucin to Enhance Probiotic Effects". International Journal of Molecular Sciences. 21 (24): 9756. doi: 10.3390/ijms21249756 . PMC   7766874 . PMID   33371288.
15. Kinoshita H, Uchida H, Kawai Y, Kawasaki T, Wakahara N, Matsuo H, Watanabe M, Kitazawa H, Ohnuma S, Miura K, Horii A, Saito T (June 2008). "Cell surface Lactobacillus plantarum LA 318 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) adheres to human colonic mucin". Journal of Applied Microbiology. 104 (6): 1667–1674. doi:10.1111/j.1365-2672.2007.03679.x. PMID   18194256. S2CID   22346488.
16. Kinoshita H, Wakahara N, Watanabe M, Kawasaki T, Matsuo H, Kawai Y, Kitazawa H, Ohnuma S, Miura K, Horii A, Saito T (1 November 2008). "Cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA 318 recognizes human A and B blood group antigens". Research in Microbiology. 159 (9–10): 685–691. doi: 10.1016/j.resmic.2008.07.005 . PMID   18790050.
17. Patel DK, Shah KR, Pappachan A, Gupta S, Singh DD (October 2016). "Cloning, expression and characterization of a mucin-binding GAPDH from Lactobacillus acidophilus". International Journal of Biological Macromolecules. 91: 338–346. doi:10.1016/j.ijbiomac.2016.04.041. PMID   27180300.
18. Zheng L, Roeder RG, Luo Y (July 2003). "S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component". Cell. 114 (2): 255–266. doi: 10.1016/S0092-8674(03)00552-X . PMID   12887926. S2CID   5543647.
19. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A (July 2005). "S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding". Nature Cell Biology. 7 (7): 665–674. doi:10.1038/ncb1268. PMID   15951807. S2CID   1922911.
20. Hara MR, Thomas B, Cascio MB, Bae BI, Hester LD, Dawson VL, Dawson TM, Sawa A, Snyder SH (March 2006). "Neuroprotection by pharmacologic blockade of the GAPDH death cascade". Proceedings of the National Academy of Sciences of the United States of America. 103 (10): 3887–3889. Bibcode:2006PNAS..103.3887H. doi: 10.1073/pnas.0511321103 . PMC   1450161 . PMID   16505364.
21. Agarwal AR, Zhao L, Sancheti H, Sundar IK, Rahman I, Cadenas E (November 2012). "Short-term cigarette smoke exposure induces reversible changes in energy metabolism and cellular redox status independent of inflammatory responses in mouse lungs". American Journal of Physiology. Lung Cellular and Molecular Physiology. 303 (10): L889–L898. doi:10.1152/ajplung.00219.2012. PMID   23064950.
22. Ralser M, Wamelink MM, Kowald A, Gerisch B, Heeren G, Struys EA, Klipp E, Jakobs C, Breitenbach M, Lehrach H, Krobitsch S (December 2007). "Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress". Journal of Biology. 6 (4): 10. doi: 10.1186/jbiol61 . PMC   2373902 . PMID   18154684.
23. Tisdale EJ, Artalejo CR (June 2007). "A GAPDH mutant defective in Src-dependent tyrosine phosphorylation impedes Rab2-mediated events". Traffic. 8 (6): 733–741. doi:10.1111/j.1600-0854.2007.00569.x. PMC   3775588 . PMID   17488287.
24. Boradia VM, Raje M, Raje CI (December 2014). "Protein moonlighting in iron metabolism: glyceraldehyde-3-phosphate dehydrogenase (GAPDH)". Biochemical Society Transactions. 42 (6): 1796–1801. doi:10.1042/BST20140220. PMID   25399609.
25. Sweeny EA, Singh AB, Chakravarti R, Martinez-Guzman O, Saini A, Haque MM, Garee G, Dans PD, Hannibal L, Reddi AR, Stuehr DJ (September 2018). "Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells". The Journal of Biological Chemistry. 293 (37): 14557–14568. doi: 10.1074/jbc.RA118.004169 . PMC   6139559 . PMID   30012884.
26. Barber RD, Harmer DW, Coleman RA, Clark BJ (May 2005). "GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues". Physiological Genomics. 21 (3): 389–395. CiteSeerX   10.1.1.459.7039 . doi:10.1152/physiolgenomics.00025.2005. PMID   15769908.
27. Piszczatowski RT, Rafferty BJ, Rozado A, Tobak S, Lents NH (August 2014). "The glyceraldehyde 3-phosphate dehydrogenase gene (GAPDH) is regulated by myeloid zinc finger 1 (MZF-1) and is induced by calcitriol". Biochemical and Biophysical Research Communications. 451 (1): 137–141. doi:10.1016/j.bbrc.2014.07.082. PMID   25065746.
28. Saygin D, Tabib T, Bittar HE, Valenzi E, Sembrat J, Chan SY, Rojas M, Lafyatis R (2008). "Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension". Pulmonary Circulation. 10 (1): 239–243. doi:10.1007/s11684-008-0045-7. PMC   7052475 . PMID   32166015. S2CID   85327763.
29. Campanella ME, Chu H, Low PS (February 2005). "Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane". Proceedings of the National Academy of Sciences of the United States of America. 102 (7): 2402–2407. Bibcode:2005PNAS..102.2402C. doi: 10.1073/pnas.0409741102 . PMC   549020 . PMID   15701694.
30. Sirover MA (December 2014). "Structural analysis of glyceraldehyde-3-phosphate dehydrogenase functional diversity". The International Journal of Biochemistry & Cell Biology. 57: 20–26. doi:10.1016/j.biocel.2014.09.026. PMC   4268148 . PMID   25286305.
31. Kumar S, Sheokand N, Mhadeshwar MA, Raje CI, Raje M (January 2012). "Characterization of glyceraldehyde-3-phosphate dehydrogenase as a novel transferrin receptor". The International Journal of Biochemistry & Cell Biology. 44 (1): 189–199. doi:10.1016/j.biocel.2011.10.016. PMID   22062951.
32. Ramos D, Pellín-Carcelén A, Agustí J, Murgui A, Jordá E, Pellín A, Monteagudo C (January 2015). "Deregulation of glyceraldehyde-3-phosphate dehydrogenase expression during tumor progression of human cutaneous melanoma". Anticancer Research. 35 (1): 439–444. PMID   25550585.
33. Wang D, Moothart DR, Lowy DR, Qian X (2013). "The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors". PLOS ONE. 8 (4): e61262. Bibcode:2013PLoSO...861262W. doi: 10.1371/journal.pone.0061262 . PMC   3631177 . PMID   23620736.
34. Phadke M, Krynetskaia N, Mishra A, Krynetskiy E (July 2011). "Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cells". Biochemical and Biophysical Research Communications. 411 (2): 409–415. doi:10.1016/j.bbrc.2011.06.165. PMC   3154080 . PMID   21749859.
35. Mazzola JL, Sirover MA (October 2002). "Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?". Neurotoxicology. 23 (4–5): 603–609. doi:10.1016/s0161-813x(02)00062-1. PMID   12428732.
36. Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N (January 2012). "Association and heterogeneity at the GAPDH locus in Alzheimer's disease". Neurobiology of Aging. 33 (1): 203.e25–203.e33. doi:10.1016/j.neurobiolaging.2010.08.002. PMC   3017231 . PMID   20864222.
37. Raje CI, Kumar S, Harle A, Nanda JS, Raje M (February 2007). "The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel transferrin receptor". The Journal of Biological Chemistry. 282 (5): 3252–3261. doi: 10.1074/jbc.M608328200 . PMID   17121833.
38. Chauhan AS, Rawat P, Malhotra H, Sheokand N, Kumar M, Patidar A, Chaudhary S, Jakhar P, Raje CI, Raje M (December 2015). "Secreted multifunctional Glyceraldehyde-3-phosphate dehydrogenase sequesters lactoferrin and iron into cells via a non-canonical pathway". Scientific Reports. 5: 18465. Bibcode:2015NatSR...518465C. doi:10.1038/srep18465. PMC   4682080 . PMID   26672975.
39. White MR, Khan MM, Deredge D, Ross CR, Quintyn R, Zucconi BE, Wysocki VH, Wintrode PL, Wilson GM, Garcin ED (January 2015). "A dimer interface mutation in glyceraldehyde-3-phosphate dehydrogenase regulates its binding to AU-rich RNA". The Journal of Biological Chemistry. 290 (3): 1770–1785. doi: 10.1074/jbc.M114.618165 . PMC   4340419 . PMID   25451934.
40. Gerlach M, Reichmann H, Riederer P (2012). "A critical review of evidence for preclinical differences between rasagiline and selegiline". Basal Ganglia. 2 (4): S9–S15. doi:10.1016/j.baga.2012.04.032.

Further reading

• Voet D, Voet JG (2010). Biochemistry. New York: Wiley. ISBN   978-0-470-57095-1.
• Stryer L, Berg JM, Tymoczko JL (2002). Biochemistry, Fifth Edition & Lecture Notebook. San Francisco: W. H. Freeman. ISBN   978-0-7167-9804-0.
• diagram of the GAPDH reaction mechanism from Lodish MCB at NCBI bookshelf
• similar diagram from Alberts The Cell at NCBI bookshelf

External links

• PDBe-KB provides an overview of all the structure information available in the PDB for Human Glyceraldehyde-3-phosphate dehydrogenase